The measurement of BNP or NT-proBNP is useful to monitor risk, to assist in decision-making regarding the ordering of imaging studies to evaluate LV remodeling, and to provide helpful objective data regarding decision-making for referral to advanced HF therapies [9]. The gene discussed is NPPB; the disease is hydrops fetalis.